Early treatment with fluvoxamine, bromhexine, cyproheptadine, and niclosamide to prevent clinical deterioration in patients with symptomatic COVID-19: a randomized clinical trial
Wannigama et al., eClinicalMedicine, 10.1016/j.eclinm.2024.102517
https://c19early.org/wannigama.html